InterventionsHuman trial

Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials

Fig. 1. Kaplan–Meier estimates, complemented by cumulative hazard ratios, for liver cancer incidence in the CEE-alone trial.
Open the figure at full size
Fig. 1. Kaplan–Meier estimates, complemented by cumulative hazard ratios, for liver cancer incidence in the CEE-alone trial.Kaplan–Meier estimates, complemented by cumulative hazard ratios, for liver cancer incidence in the CEE-alone trial.Pichardo et al.

British Journal of Cancer

The paper

Pichardo MS, Aragaki AK, Manson JE et al.

British Journal of Cancer · 16 Sep 2026

doi.org/10.1038/s41416-026-03621-9PubMed 42749856

More on Liver cancer